FTO/BCL6 Axis Identified as Therapeutic Target in Gastric Cancer Progression
FTO-mediated demethylation of BCL6 promotes gastric cancer progression by inhibiting ferroptosis.
Therapeutic Area
Therapeutic area intelligence for Gastric Cancer with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No related entities indexed yet.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.